Vapreotide acetate Catalog No.:M27831-C F[P-](F)(F)(F)(F)F

F[P-](F)(F)(F)(F)F

Smiles: COC1C=C(C[C@H](CO[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@H](CC2C=C(OC)C(O)=CC=2)CO[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)C=CC=1O

Crizotinib and TAS-115 inhibit Met phosphorylation and reverse erlotinib resistance and VEGF production triggered by HGF in PC-9 and HCC827 cells

InChi: InChI=1S/C20H21N3O2/c1-22-11-10-17-16-4-2-3-5-18(16)23(19(17)13-22)12-14-6-8-15(9-7-14)20(24)21-25/h2-9

Vapreotide acetate Catalog No.:M27831-C F[P-](F)(F)(F)(F)FVapreotide acetate (RC 160 acetate; BMY 41606 acetate) is a neurokinin 1 (NK1) receptor antagonist, with an IC50 of 330 nM. Product information CAS Number: 849479 74 9 Molecular Weight: 1191. 42 Formula: C59H74N12O11S2 Chemical Name: 2 amino N [10 (4 aminobutyl) 4 {[1 carbamoyl 2 (1H indol 3 yl)ethyl]carbamoyl} 16 [(4 hydroxyphenyl)methyl] 13 [(1H indol 3 yl)methyl] 6,9,12,15,18 pentaoxo 7 (propan 2 yl) 1,2 dithia 5,8,11,14,17 pentaazacycloicosan 19